Clinical application of platelet inhibitors in vascular diseases
β Scribed by William S. Fields
- Publisher
- John Wiley and Sons
- Year
- 1982
- Tongue
- English
- Weight
- 419 KB
- Volume
- 2
- Category
- Article
- ISSN
- 0198-6325
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Heme oxygenaseβ1 (HOβ1) catalyzes the degradation of heme to carbon monoxide (CO), iron, and biliverdin. Biliverdin is subsequently metabolized to bilirubin by the enzyme biliverdin reductase. Although interest in HOβ1 originally centered on its hemeβdegrading function, recent findings
The present study was designed to evaluate the usefulness of laboratory monitoring of antiplatelet therapy by means of a multiparametric evaluation of in vitro platelet aggregation tests in the attempt to individually optimize a given therapeutic regimen. The presence of a condition of hyperaggregab
Vascular microanastomosis of vessels that presents marked discrepancy in size can be performed without difficulty by making a longitudinal incision of the end of the smallest vessel, forming a kind of "spatula," and joined to the vessel of greater diameter.